Detalhe da pesquisa
1.
Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data.
Oncologist
; 28(2): 139-148, 2023 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36367377
2.
Long-term follow-up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer.
J Surg Oncol
; 126(8): 1442-1450, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36048146
3.
Treatment of multiple endocrine neoplasia 1/2 tumors: case report and review of the literature.
Oncology
; 84(3): 127-34, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23235517
4.
The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis.
Cancer Chemother Pharmacol
; 61(1): 167-75, 2008 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-17440727
5.
The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX.
Surg Oncol Clin N Am
; 13(4): 711-35, x, 2004 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-15350944
6.
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience.
Cancer Chemother Pharmacol
; 71(3): 663-70, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23370660